ZYNGENIA Trademark

Trademark Overview

On Wednesday, March 3, 2010, a trademark application was filed for ZYNGENIA with the United States Patent and Trademark Office. The USPTO has given the ZYNGENIA trademark a serial number of 77949022. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 28, 2013. This trademark is owned by Zyngenia, Inc.. The ZYNGENIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancers, infectious diseases, inflammatory disorders, autoimmune diseases or disorders, metabolic disorders, central nervous system disorders, and pain
zyngenia

General Information

Serial Number77949022
Word MarkZYNGENIA
Filing DateWednesday, March 3, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 28, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 27, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancers, infectious diseases, inflammatory disorders, autoimmune diseases or disorders, metabolic disorders, central nervous system disorders, and pain

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 8, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameZyngenia, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20878
Party NameZyngenia, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20878

Trademark Events

Event DateEvent Description
Monday, October 28, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 28, 2013ABANDONMENT - NO USE STATEMENT FILED
Tuesday, March 19, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 18, 2013EXTENSION 5 GRANTED
Friday, March 15, 2013EXTENSION 5 FILED
Friday, March 15, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 15, 2013TEAS EXTENSION RECEIVED
Tuesday, September 25, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 24, 2012EXTENSION 4 GRANTED
Friday, September 21, 2012EXTENSION 4 FILED
Friday, September 21, 2012TEAS EXTENSION RECEIVED
Thursday, February 16, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 15, 2012EXTENSION 3 GRANTED
Tuesday, February 14, 2012EXTENSION 3 FILED
Tuesday, February 14, 2012TEAS EXTENSION RECEIVED
Friday, August 19, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 18, 2011EXTENSION 2 GRANTED
Tuesday, August 9, 2011EXTENSION 2 FILED
Thursday, August 18, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 9, 2011TEAS EXTENSION RECEIVED
Wednesday, March 23, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 21, 2011EXTENSION 1 GRANTED
Monday, March 21, 2011EXTENSION 1 FILED
Monday, March 21, 2011TEAS EXTENSION RECEIVED
Tuesday, September 21, 2010NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 27, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 27, 2010PUBLISHED FOR OPPOSITION
Wednesday, June 23, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, June 23, 2010ASSIGNED TO LIE
Tuesday, June 8, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 7, 2010ASSIGNED TO EXAMINER
Monday, March 8, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, March 6, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

zyngenia disorders diseases metabolic central nervous pain system autoimmune inflammatory preparations